Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases
about
Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylaseTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelClinical and experimental advances in treatment of visceral leishmaniasis.Drug strategies targeting CYP51 in neglected tropical diseasesSuccessful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs.The efficacy of 2-nitrovinylfuran derivatives against Leishmania in vitro and in vivoPotent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.β-Nitrostyrenes as Potential Anti-leishmanial Agents.Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms.Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.
P2860
Q28544037-362FC47A-0F57-4482-8F62-275FF88405B7Q28553573-30D18A1B-5316-470A-AC0A-D54248947710Q33982648-C3BBBE16-E1A2-46AD-B634-63CEF36A3884Q34622554-1B19355C-AAB1-4858-BC99-FF2C84EB6BFFQ34737833-FD640D60-FB1B-4E98-9A0B-52F4BD78B0F6Q35077994-4E823CF8-D1CE-4C00-9AA1-7080410FDADCQ35606296-1D31160F-D771-4500-9304-51D1B635E188Q35810652-41B94F08-4417-41EA-BB3D-87DB1DE94277Q36075944-3774C5D7-7D40-4DDD-892A-E09CD95DA451Q37224367-A461CF27-5F9B-4F39-A43C-9ADB97BD143EQ37579675-82F074E9-6575-41F8-8390-F86779192066Q42734594-D689C8EC-C478-4A65-B38E-987151FB37DCQ46430242-E975DFCE-A981-4C6C-93CF-A5B2E4C4F498
P2860
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@ast
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@en
type
label
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@ast
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@en
prefLabel
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@ast
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@en
P2093
P2860
P356
P1476
Efficacy of the triazole SCH 5 ...... ous and visceral leishmaniases
@en
P2093
D Loebenberg
H M Al-Abdely
J R Graybill
P2860
P304
P356
10.1128/AAC.43.12.2910
P407
P577
1999-12-01T00:00:00Z